Stock Track | Core Lab Stock Plunges 7.54% in After-Hours Trading on Mixed Q4 Results and Outlook

Stock Track
30 Jan

Core Laboratories Inc. (CLB) saw its stock price plummet 7.54% in after-hours trading on Wednesday following the release of its fourth quarter and full year 2024 results.

The company reported mixed financial results for Q4 2024, with earnings per share (EPS) of $0.22 meeting analyst estimates, while revenue of $129.24 million missed expectations of $132.44 million. For the full year 2024, Core Lab's revenue grew 2.8% year-over-year to $523.8 million, and EPS increased 9% to $0.87.

While Core Lab's Reservoir Description segment experienced growth in certain international markets, its Production Enhancement business was adversely impacted by lower U.S. onshore completion activity. The company cited challenges posed by geopolitical conflicts, sanctions, and severe weather conditions in some regions as factors affecting its performance.

Looking ahead, Core Lab provided a cautious outlook for the first quarter of 2025, projecting revenue between $121 million and $127 million, with operating income ranging from $10.2 million to $12.8 million. The company expects continued volatility in crude oil markets due to global economic uncertainties and geopolitical risks.

While Core Lab remains focused on executing its strategic initiatives, including reducing debt and pursuing growth opportunities, the mixed results and cautious guidance appear to have dampened investor sentiment, leading to the after-hours stock sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10